Login
$BSIN
$1.13 +$0.01 (0.95%) Pre-market

Unaudited Condensed Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of Sep 30, 2026
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Current assets:
Cash and equivalents
Oil and natural gas sales receivables
Marketable equity securities
Commodity derivative
Other current assets
Real estate assets held for sale, net of selling costs
Total current assets
Unevaluated properties
Evaluated properties
Oil and natural gas properties under full cost method and industrial gas properties:
Evaluated properties
Evaluated oil and natural gas properties
Less accumulated depreciation, depletion and amortization
Net oil and natural gas properties
Unproved helium properties, not subject to amortization
Net oil, natural gas and helium properties
Oil, natural gas and industrial gas properties, net
Unproved industrial gas properties, not subject to amortization
Other Assets:
Property and equipment, net
Right-of-use asset
Commodity derivative
Other assets
Total other assets
Total assets
Current liabilities:
Accounts payable and accrued liabilities
Accrued compensation and benefits
Revenue and royalties payable
Commodity derivative liability
Asset retirement obligations
Lease obligation
Total current liabilities
Noncurrent liabilities:
Credit facility
Asset retirement obligations
Commodity derivative liability - noncurrent
Lease obligation, net of current
Deferred tax liability
Other noncurrent liabilities
Total noncurrent liabilities
Total liabilities
Shareholders’ equity:
Common stock, $0.01 par value; 245,000,000 shares authorized; 52,499,955 and 34,405,143 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support